Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Poston

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Environmental Epigenetics|May 17, 2018
Persistent 6-OH-BDE-47 exposure impairs functional neuronal maturation and alters expression of neurodevelopmentally-relevant chromatin remodelersRobert G Poston, Carissa J Dunn, Pushpita Sarkar, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 23, 2009
Expression patterns of hypoxic markers at the invasive margin of colorectal cancers and liver metastasesR Rajaganeshan, R Prasad, P J Guillou, et al.
International Journal of Colorectal Disease|July 3, 2008
The role of hypoxia in recurrence following resection of Dukes' B colorectal cancerR Rajaganeshan, R Prasad, P J Guillou, et al.
International Journal of Oncology|May 6, 2011
Expression of basic fibroblast growth factor in colorectal carcinomaS Gagandeep, B Green, Z Galzie, et al.
The British Journal of Surgery|July 13, 2018
Meta-analysis of prognostic factors for overall survival in patients with resected hilar cholangiocarcinomaN T E Bird, A McKenna, J Dodd, et al.
HPB Surgery : a World Journal of Hepatic, Pancreatic and Biliary Surgery|September 15, 2009
The prognostic significance of the preoperative full blood count after resection of colorectal liver metastasesK Dajani, D A O'Reilly, N De Liguori Carino, et al.
International Journal of Oncology|May 5, 2011
Mutation in the K-ras gene at codon 12 does not correlate with disease progression in colorectal carcinoma patients treated with 5-FU/folinic acid biomodulated chemotherapyM Pickard, P Sherrington, M Brett, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 1, 1996
p53 protein overexpression and response to biomodulated 5-fluorouracil chemotherapy in patients with advanced colorectal cancerM C Brett, M Pickard, B Green, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|June 22, 2011
Ablative therapies for colorectal liver metastases: a systematic reviewS Pathak, R Jones, J M F Tang, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 31, 2016
FOLFIRI plus cetuximab in patients with liver-limited or non-liver-limited RAS wild-type metastatic colorectal cancer: A retrospective subgroup analysis of the CRYSTAL studyC-H Köhne, G Poston, G Folprecht, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Environmental Epigenetics|May 17, 2018
Persistent 6-OH-BDE-47 exposure impairs functional neuronal maturation and alters expression of neurodevelopmentally-relevant chromatin remodelersRobert G Poston, Carissa J Dunn, Pushpita Sarkar, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 23, 2009
Expression patterns of hypoxic markers at the invasive margin of colorectal cancers and liver metastasesR Rajaganeshan, R Prasad, P J Guillou, et al.
International Journal of Colorectal Disease|July 3, 2008
The role of hypoxia in recurrence following resection of Dukes' B colorectal cancerR Rajaganeshan, R Prasad, P J Guillou, et al.
International Journal of Oncology|May 6, 2011
Expression of basic fibroblast growth factor in colorectal carcinomaS Gagandeep, B Green, Z Galzie, et al.
The British Journal of Surgery|July 13, 2018
Meta-analysis of prognostic factors for overall survival in patients with resected hilar cholangiocarcinomaN T E Bird, A McKenna, J Dodd, et al.
HPB Surgery : a World Journal of Hepatic, Pancreatic and Biliary Surgery|September 15, 2009
The prognostic significance of the preoperative full blood count after resection of colorectal liver metastasesK Dajani, D A O'Reilly, N De Liguori Carino, et al.
International Journal of Oncology|May 5, 2011
Mutation in the K-ras gene at codon 12 does not correlate with disease progression in colorectal carcinoma patients treated with 5-FU/folinic acid biomodulated chemotherapyM Pickard, P Sherrington, M Brett, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 1, 1996
p53 protein overexpression and response to biomodulated 5-fluorouracil chemotherapy in patients with advanced colorectal cancerM C Brett, M Pickard, B Green, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|June 22, 2011
Ablative therapies for colorectal liver metastases: a systematic reviewS Pathak, R Jones, J M F Tang, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 31, 2016
FOLFIRI plus cetuximab in patients with liver-limited or non-liver-limited RAS wild-type metastatic colorectal cancer: A retrospective subgroup analysis of the CRYSTAL studyC-H Köhne, G Poston, G Folprecht, et al.
Pageof 5